Logo

American Heart Association

  11
  0


Final ID: 4141821

Genotype and Family History as Risk Markers of Sudden Cardiac Death in Hypertrophic Cardiomyopathy

Abstract Body (Do not enter title and authors here): Introduction:
The role of genotype in sudden cardiac death (SCD) risk stratification in hypertrophic cardiomyopathy (HCM) patients is unclear. Whether family history of SCD (FHxSCD) is independently associated with SCD after correction for genotype has never been investigated.
Methods:
This observational cohort study included HCM patients who had genetic testing at Toronto General Hospital or Tufts Medical Center. FHxSCD was defined as unexplained SCD before the age of 40 or due to HCM in a first-degree family member. SARC+ was defined as the identification of a (likely) pathogenic variant in a sarcomeric gene. The combined SCD outcome included SCD, resuscitated cardiac arrest (rCA), or appropriate ICD therapy.
Results:
The study included 3258 patients [2142 (65.7%) male, 896 (27.5%) SARC+]. Over a median follow-up of 5 years (IQR 1.9–9.6), 114 (3.5%) experienced a SCD outcome (10 SCD, 27 rCA, and 77 ICD therapies).
Both FHxSCD and SARC+ were independently associated with SCD, with hazard ratios of 1.97 [1.26-3.10, P = 0.003] and 1.73 [1.15-2.59, P = 0.008], respectively (Fig. 1). Among patients with FHxSCD but no other risk markers, the cumulative proportion of SCD was 7.8% and 9.8% at 5 and 10 years in SARC+ patients, but only 2.6% and 4.6% in SARC- patients (Fig. 2).

Adding genotype to the HCM SCD risk calculator resulted in a net reclassification index of 0.162 (0.046–0.285). Compared with the original model and using a 6%/5-year cutoff, the new model identified 8 more patients with events as high-risk but also an additional 4 patients without events.

Conclusion:
In our cohort, both FHxSCD and genotype were independently associated with SCD outcomes. In patients with FHxSCD as the sole risk marker, the risk of SCD is significant (>6%/5 years) in SARC+ patients but not in SARC- patients. Adding genotype to the HCM SCD risk calculator improves its ability to discriminate between patients at high and low risk.
  • Sakhnini, Ali  ( University Health Network , Toronto , Ontario , Canada )
  • Maron, Martin  ( Lahey Hospital , Burlington , Massachusetts , United States )
  • Rakowski, Harry  ( University Health Network , Toronto , Ontario , Canada )
  • Adler, Arnon  ( University Health Network , Toronto , Ontario , Canada )
  • Montazeri, Mahdi  ( University Health Network , Toronto , Ontario , Canada )
  • Chow, Cindy  ( University Health Network , Toronto , Ontario , Canada )
  • Silver, Josh  ( University Health Network , Toronto , Ontario , Canada )
  • Saha, Sudipta  ( University Health Network , Toronto , Ontario , Canada )
  • Chan, Raymond  ( University Health Network , Toronto , Ontario , Canada )
  • Gollob, Michael  ( University Health Network , Toronto , Ontario , Canada )
  • Fan, Chun-po  ( University Health Network , Toronto , Ontario , Canada )
  • Rowin, Ethan  ( Lahey Hospital , Burlington , Massachusetts , United States )
  • Author Disclosures:
    Ali Sakhnini: DO NOT have relevant financial relationships | Martin maron: No Answer | Harry Rakowski: No Answer | Arnon Adler: DO NOT have relevant financial relationships | Mahdi Montazeri: DO NOT have relevant financial relationships | Cindy Chow: No Answer | Josh Silver: DO NOT have relevant financial relationships | Sudipta Saha: No Answer | Raymond Chan: No Answer | Michael Gollob: DO NOT have relevant financial relationships | Chun-Po Fan: DO NOT have relevant financial relationships | Ethan Rowin: DO have relevant financial relationships ; Consultant:Cytokinetics:Past (completed) ; Consultant:iRhythm:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Hypertrophic Cardiomyopathy: Making Hearts Stronger but Not Pathologic

Sunday, 11/17/2024 , 08:00AM - 09:15AM

Abstract Oral Session

More abstracts on this topic:
Association of histologic findings with long-term outcomes in symptomatic obstructive hypertrophic cardiomyopathy patients undergoing surgical myectomy

Jadam Shada, Popovic Zoran, Desai Milind, Gaballa Andrew, Alashi Alaa, Xu Bo, Thamilarasan Maran, Rodriguez E, Tan Carmela, Ospina Susan, Smedira Nicholas

Artificial Intelligence for Clinical Risk Stratification: Expert Based Risk Scores versus Online Open Source Generative Pre-Trained Transformers

Veshtaj Marinela, Omar Alaa, Alam Loba, Kim Ga Hee, Pinney Sean, Argulian Edgar

More abstracts from these authors:
The Impact of Diastolic Function on Cardiac Outcomes in Patients with Cirrhosis after Liver Transplantation

Wadid Mark, Rowin Ethan, Bedrosian Aram, Lessey Candace, Shah Jui, Dani Sourbha, Diaco Maurizio, Gadey Gautam, Qamar Amir, Malik Raza

Association of Obesity with Declines in Kidney Function in Patients with Heart Failure with Preserved Ejection Fraction

Deng Lixia, Tighiouart Hocine, Oka Tatsufumi, Tuttle Marcelle, Downey Brian, Rowin Ethan, Sarnak Mark, Mccallum Wendy

You have to be authorized to contact abstract author. Please, Login
Not Available